Kapadisp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Kapadi is a global contract research organization (CRO) supporting biotech companies with the planning, conduct, and evaluation of complex oncology trials. It provides full-service CRO and FSP support for studies in solid and liquid malignancies, immuno-oncology, and cell and gene therapies.
Financials
Revenue history (in m)
Filing timeliness
Financial statements were filed on time, on average 38 days early. 1 of 6 audited by a statutory auditor.
- 202509/07/2026
- 202408/07/2025
- 202329/03/2024
- 202209/05/2023
- 202122/06/2022
- 202028/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Clinical trial design
- Clinical trial conduct
- Clinical trial management
- Patient recruitment
- Drug safety monitoring
- Biometrics services
- Regulatory consulting
Website technology
- Contact and booking
- HubSpot
- Analytics and marketing
- Google Tag Manager
Authorized Representatives
Manner of representation
In the case of a one-person management board, joint action by a member of the management board together with a commercial proxy is required to make declarations of will and sign on behalf of the company. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations of will and sign on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Humaneva Inc | 29,104 | $786,169.64 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2018-02-27.
09 1030 1508 0000 0000 0013 9199- 52 1030 1508 0000 0000 0013 9201
- 79 1030 1508 0000 0000 0013 9200
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 81PLN 81 |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $6,779$6,779 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $7,726$7,726 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $6,785$6,785 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| KCRS.A. | $43,596,034.97 | kcrcro.com | ||
| Brillancesp. z o.o. | $3,327,685.13 | brillance.pl | ||
| Clinchoicesp. z o.o. | $2,847,034.16 | clinchoice.com | ||
| Captor TherapeuticsS.A. | $2,286,539.43 | captortherapeutics.pl | ||
| Read-GeneS.A. | $2,163,474.84 | read-gene.com | ||
| Pure Clinicalsp. z o.o. | $1,676,907.27 | pureclinical.eu | ||
| BiokineticaS.A. | $1,292,838.89 | biokinetica.com | ||
| Pikralidasp. z o.o. | $1,151,165.63 | pikralida.eu | ||
| Bioresearch Groupsp. z o.o. | $776,186.19 | bioresearch.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-08-03 | Address change (Ul. Racławicka 146, 02-117, Warszawa → Ul. Gładka 22, 02-172, Warszawa) | |
| 2024-07-30 | Share capital increase (2,520,000.00 PLN → 2,910,400.00 PLN) | |
| 2023-12-19 | Name change (Clinscience → Kapadi) | |
| 2023-04-07 | Share capital increase (1,520,000.00 PLN → 2,520,000.00 PLN) | |
| 2022-11-07 | Address change (Ul. Erazma Ciołka 10, 01-402, Warszawa → Ul. Racławicka 146, 02-117, Warszawa) |
FAQ
Last updated: 2026-07-15